Emily C. Brantley, Ph.D. - Publications

Affiliations: 
2007 University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Neuroimmunology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M. PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Research. 71: 6561-6. PMID 22009534 DOI: 10.1158/0008-5472.Can-11-1432  0.447
2011 Kim SJ, Kim JS, Kim SW, Brantley E, Yun SJ, He J, Maya M, Zhang F, Wu Q, Lehembre F, Regenass U, Fidler IJ. Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer Neoplasia. 13: 167-179. PMID 21403842 DOI: 10.1593/Neo.10806  0.361
2010 Brantley EC, Guo L, Zhang C, Lin Q, Yokoi K, Langley RR, Kruzel E, Maya M, Kim SW, Kim SJ, Fan D, Fidler IJ. Nitric oxide-mediated tumoricidal activity of murine microglial cells. Translational Oncology. 3: 380-8. PMID 21151477 DOI: 10.1593/Tlo.10208  0.35
2008 Brantley EC, Nabors LB, Gillespie GY, Choi YH, Palmer CA, Harrison K, Roarty K, Benveniste EN. Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4694-704. PMID 18676737 DOI: 10.1158/1078-0432.Ccr-08-0618  0.384
2008 Brantley EC, Benveniste EN. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Molecular Cancer Research : McR. 6: 675-84. PMID 18505913 DOI: 10.1158/1541-7786.Mcr-07-2180  0.384
Show low-probability matches.